Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
mNo edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
University of the Philippines - Manila<br /><br /> | University of the Philippines - Manila<br /><br /> | ||
Webpage shortcut: '''[http://goo.gl/xszDH goo.gl/xszDH]''' | |||
<br /><br /> | |||
'''Resource Person'''<br /> | '''Resource Person'''<br /> | ||
[http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar K. Lie]<br /> | [http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar K. Lie]<br /> | ||
Revision as of 22:04, 26 October 2012
"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila
Webpage shortcut: goo.gl/xszDH
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center